Kepos Capital’s Elanco Animal Health ELAN Stock Holding History

Kepos Capital’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-28,264	Closed	-$752K	–	376
2019 Q3	$752K	Buy	+28,264	New	+$848K	0.07%	150

Other funds holding ELAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kepos Capital's ELAN Position: Q4 2019 in Review

Kepos Capital sold out of Elanco Animal Health (ELAN) in Q4 2019, closing a stake of 28,264 shares — an estimated $752K sold.

Kepos Capital first reported a position in ELAN in Q3 2019 and held it in 1 quarter. The position peaked at $752K in Q3 2019. 400 funds tracked by Wall St. Rank hold ELAN as of Q4 2019.

Kepos Capital reported no remaining Elanco Animal Health position as of Q4 2019 after selling out during the quarter.
Kepos Capital sold 28,264 Elanco Animal Health shares in Q4 2019, an estimated $752K.
Kepos Capital first reported a position in Elanco Animal Health in Q3 2019 and held it in 1 quarter.
Kepos Capital's Elanco Animal Health position peaked at $752K in Q3 2019.
400 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2019.

Based on Kepos Capital's 13F filing for Q4 2019, filed 13 Feb 2020.